Supplemental Figure 7 from Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder

Expression and activities of EGFR and STAT3 levels in UCUB cells. Western blot analysis was conducted with lysates from UCUB cells. TSGH8301 (TSG), TCCSUP (TCC), NTUB1 (NTU) and CDDP resistance NTUB1/P (NTP).